Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.98 is in line with its 5-year average of 8.87, around the middle of its 5-year range (3.23–13.07).
As of the fiscal period ended Tuesday, June 30, 2026. 8.38% above its 12-month average of 8.29.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.98.
QUICK RATIO (ACID-TEST)
8.98
QUICK RATIO (ACID-TEST) AVG TTM
8.29
QUICK RATIO (ACID-TEST) AVG 3Y
8.03
QUICK RATIO (ACID-TEST) AVG 5Y
8.87
QUICK RATIO (ACID-TEST) AVG 10Y
5.80
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.38%
CURRENT VS 3Y AVG
+11.84%
CURRENT VS 5Y AVG
+1.30%
CURRENT VS 10Y AVG
+54.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.11
median of 688 covered companies
CURRENT VS SECTOR MEDIAN
+188.78%
vs the sector median at left
Entera Bio Ltd.
Market Cap
$127.67M
Quick Ratio (Acid-Test)
8.98
TTM Avg
8.29
3Y Avg
8.03
5Y Avg
8.87
Market Cap
$129.68M
Quick Ratio (Acid-Test)
2.70
TTM Avg
1.66
3Y Avg
3.23
5Y Avg
3.69
Market Cap
$125.34M
Quick Ratio (Acid-Test)
0.86
TTM Avg
0.23
3Y Avg
0.62
5Y Avg
0.88
Market Cap
$132.82M
Quick Ratio (Acid-Test)
1.07
TTM Avg
2.33
3Y Avg
2.66
5Y Avg
3.76
Market Cap
$123.26M
Quick Ratio (Acid-Test)
10.21
TTM Avg
11.59
3Y Avg
10.00
5Y Avg
8.96
Market Cap
$121.00M
Quick Ratio (Acid-Test)
0.18
TTM Avg
2.21
3Y Avg
2.68
5Y Avg
2.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $127.67M | 8.98 | 8.29 | 8.03 | 8.87 |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | 2.70 | 1.66 | 3.23 | 3.69 |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $125.34M | 0.86 | 0.23 | 0.62 | 0.88 |
| Organigram Global Inc. (OGI)vs › | $132.82M | 1.07 | 2.33 | 2.66 | 3.76 |
| enGene Holdings Inc. (ENGN)vs › | $123.26M | 10.21 | 11.59 | 10.00 | 8.96 |
| Cibus, Inc. (CBUS)vs › | $122.89M | 1.62 | 0.78 | 1.43 | 2.39 |
| LifeMD, Inc. (LFMD)vs › | $135.17M | 0.84 | 0.97 | 0.83 | 1.00 |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.00M | 0.18 | 2.21 | 2.68 | 2.62 |
| Freenome, Inc. (FRNM)vs › | $136.06M | N/A | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $136.52M | 1.34 | 5.45 | 5.41 | 6.46 |
Quick Ratio
8.98
Excludes inventory
Current Ratio
8.98
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.98 |
| 2026-03-31 | 7.93 |
| 2025-12-31 | 3.23 |
| 2025-09-30 | 10.83 |
| 2025-06-30 | 10.47 |
| 2025-03-31 | 13.07 |
| 2024-12-31 | 7.63 |
| 2024-09-30 | 6.61 |
| 2024-06-30 | 7.41 |
| 2024-03-31 | 8.70 |
| 2023-12-31 | 10.32 |
| 2023-09-30 | 3.95 |
| 2023-06-30 | 5.26 |
| 2023-03-31 | 7.61 |
| 2022-12-31 | 9.58 |
| 2022-09-30 | 12.73 |
| 2022-06-30 | 10.89 |
| 2022-03-31 | 9.27 |
| 2021-12-31 | 8.01 |
| 2021-09-30 | 9.72 |
| 2021-06-30 | 8.33 |
| 2021-03-31 | 1.64 |
| 2020-12-31 | 4.95 |
| 2020-09-30 | 2.67 |
| 2020-06-30 | 2.56 |
| 2020-03-31 | 2.84 |
| 2019-12-31 | 3.41 |
| 2019-09-30 | 2.65 |
| 2019-06-30 | 4.51 |
| 2019-03-31 | 4.62 |
| 2018-12-31 | 6.90 |
| 2018-09-30 | 9.87 |
| 2018-06-30 | 3.69 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 6.15 |
| 2017-09-30 | 0.23 |
| 2017-06-30 | 0.24 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.52 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
